Protein kinase inhibitors for treatment of neurological disorders
US5621101A · kind A · utility
27Cited by
7References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 7, 1995 |
| Grant date | Apr 15, 1997 |
| Priority date | — |
| Expiry date | Jun 7, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7056
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features novel derivatives of K-252a, as well as novel bis-N-substituted derivatives of staurosporine. The invention also features a method for treating diseased neuronal cells involving the administration of either the novel staurosporine derivatives or specified functional derivatives of K-252a.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.